Observing sex differences in hypoxic pulmonary vasoconstriction in humans
Summary
We are trying to see how blood vessels in our lungs react in low oxygen (hypoxia). And we want to see how the response differs between males and females. As a participant, you will come in for 2 separate visits. The first visit will involve a screening. Then you will become familiar with ultrasound scans of the heart. The second visit will involve a blood draw and then ultrasound scans in a low-oxygen chamber for 2 hours. We will take images of the heart every 40 minutes while in the chamber, and 30 minutes after exiting the chamber.
Eligibility
Eligible ages: 18 to 40
Accepts healthy participants: Yes
Inclusion criteria:
We are seeking healthy, recreationally active males and females between the age of 18-40.
Exclusion criteria:
- Obese
- Cardiorespiratory disease
- Lung disease
- Diabetes
- Heart valve disorders
- Cardiac pacemaker
- Females: Pregnant or nursing
- History of high altitude pulmonary edema
- Not exposed to altitude >2500m or air travel >4 hours within the past week
- Currently a smoker (including vaping)
- Currently undergoing hormone replacement therapy
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Victoria Chang
Principal investigator:
Paolo Dominelli
Clinical trial:
No
REB-ID:
REB25-0478